m+Medelevator.RU
← Поиск публикаций
JACC. Case reports · 2026

First-in-Human Permanent Totally Leadless Left Ventricular Septal Endocardial Pacing With Atrioventricular Synchrony.

Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Dababneh Edward, Brown Patrick, Ahmad Waheed, Rowe Matthew, Callanan Jamie, Gould Paul A

Аннотация

BACKGROUND: Leadless cardiac resynchronization combining WiSE system ultrasound-mediated left ventricular pacing with leadless right ventricular pacing has been reported. However, atrioventricular-sequential left ventricular pacing triggered by atrial leadless pacing impulse without right ventricular pacing has not been reported.

FIRST-IN-HUMAN/EARLY REPORTS SUMMARY: An 86-year-old man with complete heart block and cardiomyopathy received a dual-chamber leadless pacemaker (AVEIR DR) with WiSE left ventricular endocardial electrode on the septal wall. A novel "sync-to-pace" delay configuration enabled the atrial pacing impulse to trigger left ventricular stimulation, achieving a QRS duration of 142 ms.

DISCUSSION: This case demonstrates proof of concept for a fully leadless atrioventricular-synchronized system capable of delivering left ventricular septal endocardial pacing without right ventricular pacing dependency, offering a physiological pacing strategy for selected patients.

NOVELTY: First-in-human demonstration of an ultrasound-mediated left ventricular endocardial electrode triggered by an atrial leadless pacing impulse to deliver atrioventricular-sequential left ventricular septal stimulation without right ventricular pacing.

TAKE-HOME MESSAGE: This novel totally leadless architecture is a proof of concept for a more physiological pacing option for pacing-dependent patients while avoiding transvenous lead-related complications.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты